This study aimed to ascertain whether extracorporeal photochemotherapy (ECP) is an
effective treatment for paediatric patients with refractory graft‐versus‐host disease (GVHD) …

Background: Extracorporeal photopheresis (ExP) is an effective therapy for several
conditions including cutaneous T-cell lymphoma, scleroderma, and allograft rejection …

Background Chronic cutaneous graft-vs-host disease (GVHD) is generally classified by
whether lesions have a lichenoid or sclerodermatous morphology. Other unusual clinical …

We conducted a retrospective analysis of all allogeneic stem cell transplantation (ASCT)
patients started on extracorporeal photopheresis (ECP) for the management of steroid …

Whole‐body ultraviolet (UV) A1 (340–400 nm) phototherapy was first introduced 30 years
ago, but is currently available in the UK in only three dermatology departments. A workshop …

Ultraviolet (UV) light is known to induce skin cancers by causing DNA gene mutations and
inducing immunosuppression. Taking advantage of these immunosuppressive capacities …

Graft-versus-host disease (GVHD) is the primary cause of non-relapse-related morbidity and
mortality in patients who undergo hematopoietic stem cell transplantation. Dermatologic …

We report 28 patients with advanced chronic graft-versus-host disease (cGVHD) treated with
extracorporeal photopheresis (ECP). All had failed conventional immunosuppressive …

BACKGROUND AND OBJECTIVES: Extracorporeal chemophototherapy (ECP) is
considered an immunomodulatory agent useful in both acute and chronic graft-versus-host …

In a prior multicenter randomized controlled trial, we found that a 12-week course of
extracorporeal photopheresis (ECP) plus standard immunosuppressive therapy resulted in …